These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11077043

  • 1. Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues.
    Dabholkar M, Thornton K, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E.
    Biochem Pharmacol; 2000 Dec 01; 60(11):1611-9. PubMed ID: 11077043
    [Abstract] [Full Text] [Related]

  • 2. Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissues.
    Reed E, Dabholkar M, Thornton K, Thompson C, Yu JJ, Bostick-Bruton F.
    Oncol Rep; 2000 Dec 01; 7(5):1123-8. PubMed ID: 10948350
    [Abstract] [Full Text] [Related]

  • 3. Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.
    Yu JJ, Bicher A, Ma YK, Bostick-Bruton F, Reed E.
    Cancer Lett; 2000 Apr 14; 151(2):127-32. PubMed ID: 10738106
    [Abstract] [Full Text] [Related]

  • 4. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND, Agadjanian H, Nassanian H, Miller CW, Orsulic S, Karlan BY, Walsh CS.
    Cancer; 2012 Feb 01; 118(3):689-97. PubMed ID: 21751198
    [Abstract] [Full Text] [Related]

  • 5. Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer.
    Reed E, Yu JJ, Davies A, Gannon J, Armentrout SL.
    Clin Cancer Res; 2003 Nov 01; 9(14):5299-305. PubMed ID: 14614013
    [Abstract] [Full Text] [Related]

  • 6. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck.
    Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q.
    Cancer; 2002 Jan 15; 94(2):393-7. PubMed ID: 11900225
    [Abstract] [Full Text] [Related]

  • 7. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis.
    Cheng L, Spitz MR, Hong WK, Wei Q.
    Carcinogenesis; 2000 Aug 15; 21(8):1527-30. PubMed ID: 10910954
    [Abstract] [Full Text] [Related]

  • 8. The relative expression of mutated XPB genes results in xeroderma pigmentosum/Cockayne's syndrome or trichothiodystrophy cellular phenotypes.
    Riou L, Zeng L, Chevallier-Lagente O, Stary A, Nikaido O, Taïeb A, Weeda G, Mezzina M, Sarasin A.
    Hum Mol Genet; 1999 Jun 15; 8(6):1125-33. PubMed ID: 10332046
    [Abstract] [Full Text] [Related]

  • 9. CSB is a component of RNA pol I transcription.
    Bradsher J, Auriol J, Proietti de Santis L, Iben S, Vonesch JL, Grummt I, Egly JM.
    Mol Cell; 2002 Oct 15; 10(4):819-29. PubMed ID: 12419226
    [Abstract] [Full Text] [Related]

  • 10. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.
    Dabholkar M, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E.
    J Clin Invest; 1994 Aug 15; 94(2):703-8. PubMed ID: 8040325
    [Abstract] [Full Text] [Related]

  • 11. Differential ultraviolet-B-induced immunomodulation in XPA, XPC, and CSB DNA repair-deficient mice.
    Boonstra A, van Oudenaren A, Baert M, van Steeg H, Leenen PJ, van der Horst GT, Hoeijmakers JH, Savelkoul HF, Garssen J.
    J Invest Dermatol; 2001 Jul 15; 117(1):141-6. PubMed ID: 11442761
    [Abstract] [Full Text] [Related]

  • 12. The human CSB (ERCC6) gene corrects the transcription-coupled repair defect in the CHO cell mutant UV61.
    Orren DK, Dianov GL, Bohr VA.
    Nucleic Acids Res; 1996 Sep 01; 24(17):3317-22. PubMed ID: 8811084
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
    Kudo K, Gavin E, Das S, Amable L, Shevde LA, Reed E.
    Oncogene; 2012 Nov 01; 31(44):4718-24. PubMed ID: 22266871
    [Abstract] [Full Text] [Related]

  • 14. CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29.
    Yang Z, Liu C, Wu H, Xie Y, Gao H, Zhang X.
    BMC Cancer; 2019 Oct 15; 19(1):948. PubMed ID: 31615563
    [Abstract] [Full Text] [Related]

  • 15. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.
    Stubbert LJ, Smith JM, McKay BC.
    BMC Cancer; 2010 May 14; 10():207. PubMed ID: 20470425
    [Abstract] [Full Text] [Related]

  • 16. Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer.
    Lin K, Ye D, Xie X.
    Int J Gynecol Cancer; 2008 May 14; 18(5):1007-12. PubMed ID: 18081788
    [Abstract] [Full Text] [Related]

  • 17. The ATPase domain but not the acidic region of Cockayne syndrome group B gene product is essential for DNA repair.
    Brosh RM, Balajee AS, Selzer RR, Sunesen M, Proietti De Santis L, Bohr VA.
    Mol Biol Cell; 1999 Nov 14; 10(11):3583-94. PubMed ID: 10564257
    [Abstract] [Full Text] [Related]

  • 18. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes.
    Troelstra C, van Gool A, de Wit J, Vermeulen W, Bootsma D, Hoeijmakers JH.
    Cell; 1992 Dec 11; 71(6):939-53. PubMed ID: 1339317
    [Abstract] [Full Text] [Related]

  • 19. The Cockayne syndrome group B DNA repair protein as an anti-cancer target.
    Lu Y, Mani S, Kandimalla ER, Yu D, Agrawal S, States JC, Bregman DB.
    Int J Oncol; 2001 Dec 11; 19(6):1089-97. PubMed ID: 11713576
    [Abstract] [Full Text] [Related]

  • 20. Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein.
    Iyer N, Reagan MS, Wu KJ, Canagarajah B, Friedberg EC.
    Biochemistry; 1996 Feb 20; 35(7):2157-67. PubMed ID: 8652557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.